title: [The effect research of specific immunotherapy of allergic rhinitis and allergic rhinitis combined bronchial asthma].
abstract: OBJECTIVE
  To study the therapeutic effects of the specific immunotherapy (SIT) on allergic rhinitis and allergic rhinitis combined bronchial asthma. METHED: All patients were classified into allergic rhinitis group (AR group) with 32 patients and allergic rhinitis combined bronchial asthma group (AR+BA group) with 32 patients. Another health control group with 32 cases was designed as well. The allergens,symptom scores and therapeutic effects of the former two-group patients were analysis, and the serums of all three-group cases were extracted to evaluate the specific Immunoglobin E(sIgE), Interleukin-4 (IL-4). The SPSS13. 0 package was applied to conduct t-test and chi-square test, and the difference of P<0. 05 was regarded as statistical significance.
  
  
  RESULTS
  The main allergens of 64 patients were dermatophagoides farinae and dermatophagoides pteronyssinus. The improvement of symptom scores before and after SIT was statistical significant with P<0. 05. Although total effective rate reached 100% , AR group was superior than AR+BA group in term of the efficacy comparison, and P<0. 05 indicated the statistical significance. The serum sIgE, IL-4 values of three groups were brought into comparison, and P<0. 05 indicated the statistical significance of the difference.
  
  
  CONCLUSIONS
  The SIT on the AR, AR+BA is a safe and effective treatment, but different disease responds diversely. The long-term treatment course is recommended.
authors.forename: Bangyu
authors.initials: B
authors.lastname: Deng
authors.forename: Yunxia
authors.initials: Y
authors.lastname: Zhao
authors.forename: Yiwen
authors.initials: Y
authors.lastname: You
mesh_terms: D000485:Allergens / Q000276:immunology; D000818:Animals; D001249:Asthma / Q000628:therapy*; D040001:Dermatophagoides farinae / Q000276:immunology; D040002:Dermatophagoides pteronyssinus / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007167:Immunotherapy; D015847:Interleukin-4 / Q000097:blood; D065631:Rhinitis, Allergic / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000485:Allergens; C508598:IL4 protein, human; D015847:Interleukin-4; D007073:Immunoglobulin E